Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
J

Discussion on the Next Generation Small Molecules in CLL: 2nd Generation Covalent BTKi, Reversible BTKi, Novel PI3Ki, and Other Targets of Interest

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Jennifer Woyach
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Jennifer Woyach
0 views
October 18, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Chronic Lymphocytic Leukemia
13:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Shifting Standard of Care for Frontline Therapy of CLL: Which Patien…

Feat. N. Jain
11:37
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CLL State of the Art Update: Ibrutinib Prolongs PFS Compared to CIT,…

Feat. J. Brown
15:20
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Discussion on the Next Generation Small Molecules in CLL: 2nd Genera…

Feat. J. Woyach
05:46
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

62 y/o Male Diagnosed With CLL, Treated w/Mono Retuximab, Differenti…

Feat. A. Ferrajoli
04:13
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

72 y/o Female w/Relapsed Rai Stage IV CLL Treated w/Ibrutinib and Ri…

Feat. A. Ferrajoli
06:07
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

63 y/o Male w/Untreated CLL Rai I, Acute Hepatitis and Fever Work-Up…

Feat. A. Ferrajoli
13:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CAR-T Cell Therapy in Chronic Lymphocytic Leukemia (CLL): Manageable…

Feat. T. Siddiqi
16:05
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Reassessing Prognostic Markers (IGHV, TP53, CD49d, and B2M) in the E…

Feat. A. Wiestner
06:23
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

BTKi Acalabrutinib with anti-CD20 Obinutuzumab in Treatment-Naive an…

Feat. J. Woyach
07:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

CLL and Therapy Related Myeloid Neoplasia in Chemoimmunotherapy Era:…

Feat. A. Lenartova